Figg, W. Douglas: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes

Flegel, Willy Albert, Srivastava, Kshitij, Sissung, Tristan Michael, Goldspiel, Barry Ronald, Figg, William Douglas

Journal:

Year:

2020

File:

PDF, 187 KB

2020

2

U.S. Public Health Service Commissioned Corps pharmacists: Making a difference in advancing the nation's health

Flowers, Louis, Wick, Jeannette, Figg, William Douglas, McClelland, Robert H., Shiber, Michael, Britton, James E., Ngo, Diem-Kieu H., Borders-Hemphill, Vicky, Mead, Christina, Zee, Jerry, Huntzinger,

Journal:

Journal of the American Pharmacists Association

Year:

2009

Language:

english

File:

PDF, 541 KB

english, 2009

3

The androgen receptor gene and its influence on the development and progression of prostate cancer

Jeffrey S. Montgomery, Douglas K. Price, William D. Figg

Journal:

The Journal of Pathology

Year:

2001

Language:

english

File:

PDF, 127 KB

english, 2001

4

Association of a CYP17 Polymorphism with Overall Survival in Caucasian Patients with Androgen-Independent Prostate Cancer

Akinobu Hamada, Romano Danesi, Douglas K. Price, Tristan Sissung, Cindy Chau, David Venzon, Alex Sparreboom, William L. Dahut, William D. Figg

Journal:

Year:

2007

Language:

english

File:

PDF, 120 KB

english, 2007

5

The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer

Cude, Kelly J., Montgomery, Jeffrey S., Price, Douglas K., Dixon, Shannon C., Kincaid, Randall L., Kovacs, Karl F., Venzon, David J., Liewehr, David J., Johnson, Margaret E., Reed, Eddie, Figg, Willia

Journal:

Urologia Internationalis

Year:

2002

Language:

english

File:

PDF, 236 KB

english, 2002

6

Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivation

Srivastava, Anjali, Price, Douglas K, Figg, William D

Journal:

Cancer Biology & Therapy

Year:

2014

Language:

english

File:

PDF, 4.43 MB

english, 2014

7

Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: biomarker for treatment selection exclusion or inclusion?

Leibrand, Crystal R., Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2016

Language:

english

File:

PDF, 541 KB

english, 2016

8

The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity

Rui Gao, Kelie Reece, Tristan Sissung, Eddie Reed, Douglas K. Price, William D. Figg

Journal:

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Year:

2011

Language:

english

File:

PDF, 542 KB

english, 2011

9

Sarcosine as a potential prostate cancer biomarker and therapeutic target

Baum, Caitlin E., Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2010

Language:

english

File:

PDF, 146 KB

english, 2010

10

Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis

Singh, Arun, MacPherson, Gordon, Price, Douglas, Schimel, Daniel, Figg, William

Journal:

Oncology Reports

Year:

2006

Language:

english

File:

PDF, 161 KB

english, 2006

11

Meningeal Carcinomatosis in Metastatic Prostate Cancer: A Case Report

Eddie Reed, Douglas Matthews, Valerie Dyer, William D. Figg

Journal:

The Prostate Journal

Year:

1999

Language:

english

File:

PDF, 117 KB

english, 1999

12

YAP Controls Transcriptional Elongation through CKD9 recruitment for Proximal Pause Release: “Hippo-Thetical”, New Therapeutic Targets?

Kyritsi, Fiorina, Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2016

Language:

english

File:

PDF, 712 KB

english, 2016

13

Genetic variant associated with aggressive not indolent prostate cancer

Kirkland, C. Tyler, Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2010

File:

PDF, 333 KB

2010

14

BET bromodomain inhibitors—A novel epigenetic approach in castration-resistant prostate cancer

Lochrin, Sarah E, Price, Douglas K, Figg, William D

Journal:

Cancer Biology & Therapy

Year:

2014

Language:

english

File:

PDF, 90 KB

english, 2014

15

hTert-Immortalized Endothelial Cells: An Important New Research Tool

Price, Douglas K., Figg, II, William

Journal:

Year:

2004

Language:

english

File:

PDF, 171 KB

english, 2004

16

Genetic stability of tumor microenvironment

Danish, Matthew, Sissung, Tristan, K. Price, Douglas, D. Figg, William

Journal:

Cancer Biology & Therapy

Year:

2008

Language:

english

File:

PDF, 251 KB

english, 2008

17

Synthesis of a stable and orally bioavailable englerin analogue

Fash, David M., Peer, Cody J., Li, Zhenwu, Talisman, Ian J., Hayavi, Sima, Sulzmaier, Florian J., Ramos, Joe W., Sourbier, Carole, Neckers, Leonard, Figg, W. Douglas, Beutler, John A., Chain, William

Journal:

Bioorganic & Medicinal Chemistry Letters

Year:

2016

Language:

english

File:

PDF, 543 KB

english, 2016

18

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

Huang, Phoebe A., Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2018

Language:

english

File:

PDF, 1.36 MB

english, 2018

19

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

Ilaria Pastina, Elisa Giovannetti, Aldo Chioni, Tristan M Sissung, Francesco Crea, Cinzia Orlandini, Douglas K Price, Claudia Cianci, William D Figg, Sergio Ricci, Romano Danesi

Journal:

Year:

2010

Language:

english

File:

PDF, 275 KB

english, 2010

20

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer

Reece, Kelie M, Richardson, Emily D, Cook, Kristina M, Campbell, Tessa J, Pisle, Stephen T, Holly, Alesia J, Venzon, David J, Liewehr, David J, Chau, Cindy H, Price, Douglas K, Figg, William D

Journal:

Molecular Cancer

Year:

2014

Language:

english

File:

PDF, 649 KB

english, 2014

21

DNA microarrays: Tissue removal and processing affects gene expression

Ockers, Sandra, Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2006

Language:

english

File:

PDF, 384 KB

english, 2006

22

Temporal-Mediated FGFR1 independence: Implications for targeting candidate molecules in prostate cancer

Miles, Robert J., Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2008

Language:

english

File:

PDF, 659 KB

english, 2008

23

Mechanisms of Disease: polymorphisms of androgen regulatory genes in the development of prostate cancer

Singh, Arun S, Chau, Cindy H, Price, Douglas K, Figg, William D

Journal:

Nature Clinical Practice Urology

Year:

2005

Language:

english

File:

PDF, 192 KB

english, 2005

24

ANDROGEN RECEPTOR VARIATION AFFECTS PROSTATE CANCER PROGRESSION AND DRUG RESISTANCE

McCrea, Edel, Sissung, Tristan M., Price, Douglas K., Chau, Cindy H., Figg, William D.

Journal:

Pharmacological Research

Year:

2016

Language:

english

File:

PDF, 629 KB

english, 2016

25

Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

Alan R. Kristal, Douglas K. Price, Cathee Till, Jeannette M. Schenk, Marian L. Neuhouser, Sandy Ockers, Daniel W. Lin, Ian M. Thompson, William D. Figg

Journal:

Year:

2010

Language:

english

File:

PDF, 95 KB

english, 2010

26

Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model

Haiqing Li, Valentina Raia, Francesco Bertolini, Douglas K. Price, William D. Figg

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 167 KB

english, 2008

27

Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

William D. Figg, Erwin A. Kruger, Douglas K. Price, Sonia Kim, William D. Dahut

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 146 KB

english, 2002

28

Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study

Alison Ehrlich, Susan Booher, Yvonne Becerra, Debra L Borris, W.Douglas Figg, Maria L Turner, Andrew Blauvelt

Journal:

Journal of the American Academy of Dermatology

Year:

2004

Language:

english

File:

PDF, 295 KB

english, 2004

29

Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer

Hulin-Curtis, Sarah L, Petit, Dominique, Figg, W Douglas, Hsing, Ann W, Reichardt, Juergen KV

Journal:

Future Oncology

Year:

2010

Language:

english

File:

PDF, 1.04 MB

english, 2010

30

Precision Oncology Medicine: The Clinical Relevance of Patient Specific Biomarkers Used to Optimize Cancer Treatment

Schmidt, Keith T., Chau, Cindy H., Price, Douglas K., Figg, William D.

Journal:

Journal of Clinical Pharmacology

Year:

2016

Language:

english

File:

PDF, 177 KB

english, 2016

31

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT

Handy, Whitney F., Schmidt, Keith T., Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2020

File:

PDF, 1.26 MB

2020

32

Approaches to preclinical screening of antiangiogenic agents

Kruger, Erwin A., Duray, Paul H., Price, Douglas K., Pluda, James M., Figg, William D.

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 9.31 MB

english, 2001

33

Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial

Figg, William D., Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Cho, Yonggon, Varella-Garcia, Marileila, Reichardt, Juergen K.V., Tangen, Catherine M., Leach, Robin J., van Bok

Journal:

Year:

2014

Language:

english

File:

PDF, 279 KB

english, 2014

34

A Phase I Clinical Study of High Dose Ketoconazole Plus Weekly Docetaxel for Metastatic Castration Resistant Prostate Cancer

Figg, William D., Woo, Sukyung, Zhu, Wenhui, Chen, Xiaohong, Ajiboye, A. Seun, Steinberg, Seth M., Price, Douglas K., Wright, John J., Parnes, Howard L., Arlen, Philip M., Gulley, James L., Dahut, Wil

Journal:

The Journal of Urology

Year:

2010

Language:

english

File:

PDF, 1.02 MB

english, 2010

35

Medulloblastoma cell line secretes platelet-derived growth factor

Whelan, Harry T., Nelson, David B., Strother, Douglas, Przybylski, Cynthia, Figge, Gary, Mamandi, Afsheen

Journal:

Pediatric Neurology

Year:

1989

Language:

english

File:

PDF, 443 KB

english, 1989

36

Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers

Horenstein, Richard B., Madabushi, Rajnikanth, Zineh, Issam, Yerges-Armstrong, Laura M., Peer, Cody J., Schuck, Robert N., Figg, William Douglas, Shuldiner, Alan R., Pacanowski, Michael A.

Journal:

Journal of Clinical Pharmacology

Year:

2014

Language:

english

File:

PDF, 446 KB

english, 2014

37

A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer

Nima Sharifi, Akinobu Hamada, Tristan Sissung, Romano Danesi, David Venzon, Caitlin Baum, James L. Gulley, Douglas K. Price, William L. Dahut, William D. Figg

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 168 KB

english, 2008

38

Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer

Jeanny B. Aragon-Ching, John Gillespie, Douglas K. Price, Rodrigo Chuaqui, Jaime Rodriguez-Canales, Seth M. Steinberg, William L. Dahut, William D. Figg

Journal:

BJU International

Year:

2007

Language:

english

File:

PDF, 95 KB

english, 2007

39

Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy

Johnson, Linda M., Price, Douglas K., Figg, William D

Journal:

Cancer Biology & Therapy

Year:

2013

Language:

english

File:

PDF, 561 KB

english, 2013

40

Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer

Sissung, Tristan M, Deeken, John, Leibrand, Crystal R, Price, Douglas K, Ehrlich, Sheryl, Steinberg, Seth M, Liewehr, David J, Dahut, William, Figg, William D

Journal:

Pharmacogenomics

Year:

2016

Language:

english

File:

PDF, 1.06 MB

english, 2016

41

Prostate cancer progression attributed to autonomic nerve development

Fernández, Elena V, Price, Douglas K, Figg, William D

Journal:

Cancer Biology & Therapy

Year:

2013

Language:

english

File:

PDF, 551 KB

english, 2013

42

VEGF inhibition and metastasis: Possible implications for antiangiogenic therapy

English, Bevin C., Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2009

Language:

english

File:

PDF, 284 KB

english, 2009

43

Genotyping and functional analysis of the D104N variant of human endostatin

Macpherson, Gordon R., Singh, Arun S., Bennett, Charles L., Venzon, David J., Liewehr, David J., Franks, Michael E., Dahut, William L., Kantoff, Philip W., Price, Douglas K., Figg, II, William

Journal:

Cancer Biology & Therapy

Year:

2004

Language:

english

File:

PDF, 896 KB

english, 2004

44

Current status of thalidomide and its role in the treatment of metastatic prostate cancer

Gordon R. Macpherson, Michael Franks, Andrada Tomoaia-Cotisel, Yuichi Ando, Douglas K Price, William D. Figg

Journal:

Critical Reviews in Oncology/Hematology

Year:

2003

Language:

english

File:

PDF, 241 KB

english, 2003

45

Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer

David L. Bartlett, Steven K. Libutti, William D. Figg, Douglas L. Fraker, H.Richard Alexander

Journal:

Year:

2001

Language:

english

File:

PDF, 361 KB

english, 2001

46

Genetic variant associated with aggressive not indolent prostate cancer

Kirkland, C. Tyler, Price, Douglas K., Figg, William D.

Journal:

Cancer Biology & Therapy

Year:

2010

Language:

english

File:

PDF, 333 KB

english, 2010

47

Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32.

Sissung, Tristan M., Chau, Cindy, Price, Douglas K., Figg, William D.

Journal:

Drug Metabolism Letters

Year:

2018

Language:

english

File:

PDF, 193 KB

english, 2018

48

The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor

Liang, Xiaobing, Guo, Yi, Figg, William Douglas, Fojo, Antonio Tito, Mueller, Michael D., Yu, Jing Jie

Journal:

Chemotherapy Research and Practice

Year:

2011

Language:

english

File:

PDF, 1.16 MB

english, 2011

49

Polymorphism in the hypoxia-inducible factor 1α gene may confer susceptibility to androgen-independent prostate cancer

Chau, Cindy H., Permenter, Matthew G., Steinberg, Seth M., Retter, Avi S., Dahut, William L., Price, Douglas K., Figg, II, William

Journal:

Cancer Biology & Therapy

Year:

2005

Language:

english

File:

PDF, 726 KB

english, 2005

50

Mapping a path for cancer precision medicine

Price, Douglas K, Chau, Cindy H, Figg, William D

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 75 KB

english, 2017

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски